Raj Jitendra Chovatiya MD PhD
Clinical Associate Professor | Rosalind Franklin University Chicago Medical School Founder and Director | Center for Medical Dermatology and Immunology Research
Join to View Full Profile
3000 N Halsted StSuite 301Chicago, IL 60657
Dr. Chovatiya is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Northwestern UniversityMS, Clinical Investigation, 2021 - 2023
McGaw Medical Center of Northwestern UniversityResidency, Dermatology, 2017 - 2020
Yale-New Haven Medical CenterInternship, Internal Medicine, 2016 - 2017
Yale School of MedicineClass of 2016- Yale UniversityPhD, Immunobiology, 2014
Certifications & Licensure
IL State Medical License 2017 - 2026
American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- Patient and healthcare provider perspectives on treatment patterns and patient satisfaction of seborrheic dermatitis in the United States.Raj Chovatiya, Christy H Chang, Lakshi Aldredge, Candrice Heath, Moises Acevedo
The Journal of Dermatological Treatment. 2025-12-01 - Correction to: Real-World Evidence of Tralokinumab Effectiveness and Safety: A Systematic Review and Meta-analysis.Amalie Thorsti Møller Rønnstad, Christopher G Bunick, Raj Chovatiya, Masahiro Kamata, Mia-Louise Nielsen
American Journal of Clinical Dermatology. 2025-04-24 - Type 2 Inflammation and Its Role in Dermatologic Diseases.Raj Chovatiya, Jason E Hawkes, Douglas DiRuggiero, Leigh Ann Pansch, Elizabeth Simcox
International Journal of Dermatology. 2025-03-22
Press Mentions
LEO Pharma Survey: Dermatology Providers Agree Chronic Hand Eczema Impacts Patients’ Emotional, Social and Occupational Well-BeingApril 22nd, 2025- Lilly's EBGLYSS® (Lebrikizumab-Lbkz) Single Monthly Maintenance Injection Achieved Completely Clear Skin at Three Years in Half of Patients with Moderate-to-Severe Atopic DermatitisMarch 7th, 2025
- No Clear Connection Between Psoriasis and Seborrhoeic DermatitisNovember 15th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
